Patent · US Active

Drug eluting expandable devices

US10285968B2 · kind B2 · utility

0Cited by
24References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2018
Grant dateMay 14, 2019
Priority date
Expiry dateMar 13, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/802
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.